Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Heebøll, Sara; Risikesan, Jeyanthini; Ringgaard, Steffen; Kumarathas, Indumathi; Sandahl, Thomas D; Grønbæk, Henning; Søndergaard, Esben; Nielsen, Søren

Heebøll, Sara; Risikesan, Jeyanthini; Ringgaard, Steffen; Kumarathas, Indumathi; Sandahl, Thomas D; Grønbæk, Henning; Søndergaard, Esben; Nielsen, Søren.

Afiliación

Heebøll S; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Risikesan J; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
Ringgaard S; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
Kumarathas I; Department of Internal Medicine, Regional Hospital Viborg, Viborg, Denmark.
Sandahl TD; Magnetic Resonance Research Centre, Aarhus University, Aarhus, Denmark.
Grønbæk H; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
Søndergaard E; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Nielsen S; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Diabetes ; 71(11): 2402-2411, 2022 11 01.

Article en En | MEDLINE | ID: mdl-36001750

Asunto(s)

Glucagón; Hepatopatías; Humanos; Glucagón/metabolismo; Octreótido/metabolismo; Insulina/metabolismo; Lipoproteínas VLDL/metabolismo; Triglicéridos/metabolismo; Glucosa/metabolismo; Hígado/metabolismo; Somatostatina/metabolismo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucagón / Hepatopatías Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google